Navigation Links
United Therapeutics Corporation Reports Second Quarter 2014 Financial Results
Date:7/29/2014

SILVER SPRING, Md., July 29, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2014.

"Our continued growth shows that our medicines are reaching increasing numbers of patients suffering from pulmonary arterial hypertension (PAH)," said Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer. "The commercial launch this quarter of our extended-release tablet called Orenitram® harkens an opportunity to bring prostacyclin-based medicine to more PAH patients in the U.S. than ever before, by providing a less-invasive route of administration than our prostacyclin infusion therapy called Remodulin®."

Total revenues for the quarter ended June 30, 2014 were $322.8 million, up from $280.6 million for the quarter ended June 30, 2013. Net income for the quarter ended June 30, 2014 was $111.9 million or $2.35 per basic share, compared to $79.9 million or $1.60 per basic share for the same quarter in 2013. Gross margin from sales was $282.6 million for the quarter ended June 30, 2014, compared to $245.2 million for the same quarter last year. Non-GAAP earnings(1) for the quarter ended June 30, 2014 were $122.4 million, compared to $125.1 million for the same quarter in 2013.(1)

See definition of non-GAAP earnings, a non-GAAP financial measure, and a reconciliation of net income to non-GAAP earnings below.Financial Results for the Three Months Ended June 30, 2014 Revenues

The table below summarizes the components of net revenues (dollars in thousands):Three Months Ended
June 30,Percentage
Change20142013Cardiopulmonary products:Remodulin

'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. AMA’s National Model Aviation Museum Granted Full Civilian Museum Certification by the National Museum of the United States Air Force
2. United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014
3. United States Non-Vascular Stents Market Outlook to 2020
4. Researchmoz
5. Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals
6. United Nations Proclaims an International Year of Light in 2015
7. ACLS, BLS and PALS Training Institution United Medical Education Updates its Training Materials
8. United Technologies plans $10 million investment for UConn systems engineering institute
9. TrialNetworks Co-founder and Chairman Vivek Murthy, MD, MBA, Nominated by President Barack Obama as Surgeon General of the United States of America
10. ABET Approves Criteria for Optics and Photonics Engineering Undergraduate Degrees in United States
11. United Therapeutics Corporation Reports Third Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... has appointed Francois Vieillard as Sales & Marketing Director. , With more ... Vieillard will be responsible for reinforcing Tronics’ business development activities worldwide. He brings ...
(Date:7/30/2015)... CITY, Kan. , July 30, 2015 /PRNewswire/ ... ), a pet therapeutics company focused on the ... for companion animals, today announced that its strategic ... from a dose confirmation study of AT-016, an ... Aratana for the treatment of osteoarthritis pain in ...
(Date:7/30/2015)... HIGHLIGHTS:Q2 2015 Results (all changes ... Reported sales were $697 million compared to $701 million ... by 8%, and changes in foreign currency exchange rates ... 1%. , By business unit, organic sales growth ... in SAFC Commercial. , Reported diluted EPS was ...
(Date:7/29/2015)... , July 30, 2015 ... results for the second quarter of 2015. CEO ... results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered ... results - Performance drivers ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... LAUSANNE, Switzerland and TAMPA, ... global biopharmaceutical group,of companies with a focus on ... needs, and Moffitt Cancer Center (Moffitt), a non-profit,Florida ... agreement,for the development and commercialization of Debio 0928, ...
... N.J., June 17 Johnson & Johnson (NYSE: ... granted early termination of the waiting period under the Hart-Scott-Rodino ... acquisition of Cougar Biotechnology (Nasdaq: CGRB ). ... wholly owned subsidiary, Kite Merger Sub, Inc., initiated a cash ...
... (PI), a leading provider of specialized training solutions for the ... new e-course titled, Introduction to Health Policy . ... Managed Markets Excellence(TM) series. The new Introduction ... the challenges confronting the US healthcare system. , ...
Cached Biology Technology:Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours 2Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours 3Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology 2Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology 3Pharmaceutical Institute Launches New E-Course Focused on Health Policy 2Pharmaceutical Institute Launches New E-Course Focused on Health Policy 3
(Date:7/8/2015)... July 8, 2015 The consumer products ... summer,s must have products such as wearables, smart wallets & ... for biometrics based devices continues to rapidly grow.  Biometrics & ... NXTD ), Google Inc. (NASDAQ: GOOG ), Apple ... ), GoPro, Inc. (NASDAQ: GPRO ) and Baidu Inc. ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
Breaking Biology News(10 mins):Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... have discovered a subpopulation of cells that display cancer ... in tumor progression. This breakthrough could lead to the ... tests, and innovative therapeutic strategies, as reported in ... is a frequent and devastating phenomenon that occurs in ...
... Spanish . , A U.S. Department of ... and other crop pests by using plants as storehouses for ... on the pests attacking those crops. Cindy L. McKenzie, ... Research Unit at Fort Pierce, Fla., has done extensive work ...
... since the 1980s may explain significant increases in zinc ... Rocky Mountain watershed, reports a new study led by ... Boulder. Rising concentrations of zinc and other metals ... Continental Divide near Keystone, Colo., may be the result ...
Cached Biology News:Researchers reveal a chemo-resistant cancer stem cell as cancer's 'Achilles' heel' 2Researchers use 'banker plants' to help battle whitefly pests 2Increase in metal concentrations in Rocky Mountain watershed tied to warming temperatures 2Increase in metal concentrations in Rocky Mountain watershed tied to warming temperatures 3
A collection of 42 spots with normal tissues from different organs of C57 mice, rat and human....
... Fujifilm Life Science FLA-7000 excels at fluorescent ... gel documentation. It features four easy-to-access filters ... a filter for Imaging Plates) for upgrading ... customizable choice of four kinds of excitation ...
... Array Analyst Software has been optimized for ... algorithms allow the software to quickly and ... each well of an ELISA plate or ... Analyst Software has been customized to incorporate ...
For microscopy...
Biology Products: